Close Menu

This article previously reported that Cepheid's technology is being used by government health and law-enforcement officials in New York, Nevada, and Florida to investigate reports of anthrax. While Cepheid acknowledges that its DNA-analysis instruments are being used by these agencies, the company cannot comment whether the products are being used in any specific anthrax case in those states.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.